Thursday 15 September 2022

Venue: Utrecht Science Park, Lecture hall C1.02, Androclus building, Yalelaan 1, Utrecht

Deadline for registration: Thursday 1 September 2022

The theme of the 2022 edition will be Lessons learnt from COVID-19 Vaccination.

Previous editions covered topics like Vaccines and pathogen adaptation, Development of a COVID-19 vaccine, Structural Vaccinology, Novel Vaccine Platforms, The powerful contribution of vectors to vaccine-induced immunity, Vaccination in the Elderly, Maternal vaccination, Vector-borne diseases, Vaccines and re-emerging infections and Innovative vector approaches in vaccination.

The symposium will be open for all interested at no charge, it is however necessary to register below.

Program 2022

09.30      Cécile van Els, RIVM & Biomolecular Health Sciences, Veterinary Medicine, Utrecht University
09.40 Rogier Sanders, Medical Microbiology and Infection Prevention, Amsterdam UMC
"Structural Vaccine Design for Spike Protein-based vaccines"
10.30 Rory de Vries, Viroscience, Erasmus Medical Center, Rotterdam
“Humoral and cellular immune mechanisms induced by COVID-19 vaccines: cross-reactivity against Variants of Concern?”
11.00 Break
11.20 Corine Geurts van Kessel, Viroscience, Erasmus Medical Center, Rotterdam
“Switching of COVID-19 vaccines in prime-boost schedules; a practical solution or strategy to optimize effectiveness?”
12.00 Lunch break
12.40 Dinja Oosterhoff, Intravacc, Bilthoven
“Improving Covid-19 vaccination: vaccine candidates inducing Mucosal Immunity”
13.20 Daniel L. Hurdiss, Biomolecular Health Sciences, Veterinary Medicine, Utrecht University
“Mapping vulnerable sites on the SARS-CoV-2 spike protein”
14.00 Break
14.30 Sophie Bots, Utrecht Institute for Pharmaceutical Sciences, Utrecht University
“The art of rapid safety evaluation studies in the context of COVID-19 vaccines; balancing a need for speed with reliable and robust research”
14.45 Mirte Pascha,Section Viorology, Veterinary Faculty, Utrecht University
“Mosaic N1 and N2 neuraminidase nanoparticles induce high antibody titers and potent protection from Influenza A virus H1N1 and H3N2 challenge”
15.00 Linda van Oosten, Laboratory of Virology, Wageningen University & Research
“A two-component S1-nanoparticle vaccine protects against SARS-CoV-2 challenge in K18-hACE2 mice”
15.15 Sebastiaan de Graaf, Bijvoet Center for Biomolecular Research, Utrecht University
“Exploring the human milk IgA1 response to SARS-CoV-2 vaccination at the clonal level”


End of the symposium